/PDEX
PDEX Stock - Pro-Dex, Inc.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$38.68-8.30%
$3.50 (-8.30%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.52
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $42.55
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PDEX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$38.29 – $39.07
TARGET (TP)$44.48
STOP LOSS$35.59
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.09
52W High$70.26
52W Low$23.47
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $66.59M | $53.84M | $46.09M | $42.04M | $42.04M |
| Gross Profit | $19.51M | $14.55M | $12.75M | $13.13M | $13.13M |
| Gross Margin | 29.3% | 27.0% | 27.7% | 31.2% | 31.2% |
| Operating Income | $10.69M | $7.17M | $5.76M | $5.12M | $5.12M |
| Net Income | $8.98M | $2.13M | $7.07M | $4.57M | $4.57M |
| Net Margin | 13.5% | 4.0% | 15.3% | 10.9% | 10.9% |
| EPS | $2.73 | $0.61 | $1.98 | $1.26 | $1.17 |
Company Overview
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PDEXBeat Rate
50%
Last 18 quarters
Avg Surprise
+17.9%
EPS vs Estimate
Beats / Misses
9/8
1 met exactly
Latest EPS
$0.62
Q4 2025
EPS Surprise History
Q1 24
-60.0%
$0.14vs$0.35
Q2 24
-45.7%
$0.19vs$0.35
Q3 24
+31.4%
$0.46vs$0.35
Q4 24
+158.6%
$0.75vs$0.29
Q1 25
+60.5%
$0.61vs$0.38
Q2 25
+108.5%
$0.98vs$0.47
Q3 25
-23.4%
$0.36vs$0.47
Q4 25
+24.0%
$0.62vs$0.50
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Jan 29, 2026 | $0.59 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.50 | $0.62 | +24.0% | ✓ BEAT |
Q3 2025 | Sep 4, 2025 | $0.47 | $0.36 | -23.4% | ✗ MISS |
Q2 2025 | May 1, 2025 | $0.47 | $0.98 | +108.5% | ✓ BEAT |
Q1 2025 | Jan 30, 2025 | $0.38 | $0.61 | +60.5% | ✓ BEAT |
Q4 2024 | Oct 31, 2024 | $0.29 | $0.75 | +158.6% | ✓ BEAT |
Q3 2024 | Sep 5, 2024 | $0.35 | $0.46 | +31.4% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.35 | $0.19 | -45.7% | ✗ MISS |
Q1 2024 | Feb 8, 2024 | $0.35 | $0.14 | -60.0% | ✗ MISS |
Q4 2023 | Oct 13, 2023 | $0.32 | $0.42 | +31.2% | ✓ BEAT |
Q3 2023 | Sep 29, 2023 | $0.33 | $0.38 | +15.2% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.26 | $0.36 | +38.5% | ✓ BEAT |
Q1 2023 | Feb 2, 2023 | $0.29 | $0.24 | -17.2% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $0.33 | $0.29 | -12.1% | ✗ MISS |
Q3 2022 | Aug 25, 2022 | $0.18 | $0.38 | +111.1% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.33 | $0.12 | -63.6% | ✗ MISS |
Q1 2022 | Feb 3, 2022 | $0.28 | $0.25 | -10.7% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $0.28 | $0.28 | 0.0% | = MET |
Q3 2021 | Aug 26, 2021 | $0.29 | $0.22 | -24.1% | ✗ MISS |
Latest News
Pro-Dex Extends Contract With Its Largest Customer From Dec. 31, 2025 To Dec. 31, 2028.
📈 PositiveBenzinga•Dec 19, 2025, 09:01 PM
Pro-Dex shares are trading higher after the company reported better-than-expected Q1 financial results.
📈 PositiveBenzinga•Oct 31, 2025, 03:33 PM
Pro-Dex Q1 EPS $1.40 Beats $0.50 Estimate, Sales $18.530M Beat $15.300M Estimate
📈 PositiveBenzinga•Oct 30, 2025, 08:27 PM
Pro-Dex Issues Clarification That It Has No Affiliation Or Relationship With Polkadex, A Cryptocurrency Trading Under The Same PDEX Symbol On Certain Exchanges
➖ NeutralBenzinga•Oct 16, 2025, 08:02 PM
Pro-Dex Revenue Jumps 16% in Fiscal Q4
📈 PositiveThe Motley Fool•Sep 4, 2025, 08:51 PM
Frequently Asked Questions about PDEX
What is PDEX's current stock price?
Pro-Dex, Inc. (PDEX) is currently trading at $38.68 per share. The stock has moved -8.30% today.
What is the analyst price target for PDEX?
No analyst price targets are currently available for this stock.
What sector is Pro-Dex, Inc. in?
Pro-Dex, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is PDEX's market cap?
Pro-Dex, Inc. has a market capitalization of $0.13 billion, making it a small-cap company.
Does PDEX pay dividends?
No, Pro-Dex, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPYX
Apyx Medical Corporation
$3.49
Mkt Cap: $0.1B
CGTX
Cognition Therapeutics, Inc.
$1.54
Mkt Cap: $0.1B
GLSI
Greenwich LifeSciences, Inc.
$13.01
Mkt Cap: $0.2B
IXHL
Incannex Healthcare Limited
$0.44
Mkt Cap: $0.0B
LUCD
Lucid Diagnostics Inc.
$1.12
Mkt Cap: $0.1B
MBOT
Microbot Medical Inc.
$2.08
Mkt Cap: $0.1B
RPID
Rapid Micro Biosystems, Inc.
$3.15
Mkt Cap: $0.1B
SERA
Sera Prognostics, Inc.
$3.55
Mkt Cap: $0.1B
STSS
Sharps Technology, Inc.
$2.22
Mkt Cap: $0.1B
TVGN
Tevogen Bio Holdings Inc.
$0.38
Mkt Cap: $0.1B
Explore stocks similar to PDEX for comparison